These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 16625479

  • 1. [Reverse remodeling -- paradigm shift in the treatment of pulmonary hypertension].
    Ghofrani HA, Schermuly RT, Weissmann N, Seeger W, Grimminger F.
    Dtsch Med Wochenschr; 2006 Apr 21; 131(16):871-4. PubMed ID: 16625479
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Sildenafil 20 mg. Pulmonary arterial hypertension: for oral treatment, no better than bosentan.
    Prescrire Int; 2006 Dec 21; 15(86):221. PubMed ID: 17167928
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Oral sildenafil prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats.
    Liu H, Liu ZY, Guan Q.
    Interact Cardiovasc Thorac Surg; 2007 Oct 21; 6(5):608-13. PubMed ID: 17670742
    [Abstract] [Full Text] [Related]

  • 6. Pathophysiology of acute pulmonary vasoconstriction.
    Kulik TJ.
    Pediatr Crit Care Med; 2010 Mar 21; 11(2 Suppl):S10-4. PubMed ID: 20216155
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Preoperative administration of PDE-5 Inhibitors.
    Edwards AF, Roy RC.
    J Clin Anesth; 2009 Mar 21; 21(2):149; author reply 149-50. PubMed ID: 19329023
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Dana Point: what is new in the treatment of pulmonary hypertension?].
    Hoeper MM, Ghofrani HA, Grimminger F, Rosenkranz S.
    Dtsch Med Wochenschr; 2008 Oct 21; 133 Suppl 6():S191-5. PubMed ID: 18814094
    [Abstract] [Full Text] [Related]

  • 13. Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy.
    Schermuly RT, Pullamsetti SS, Kwapiszewska G, Dumitrascu R, Tian X, Weissmann N, Ghofrani HA, Kaulen C, Dunkern T, Schudt C, Voswinckel R, Zhou J, Samidurai A, Klepetko W, Paddenberg R, Kummer W, Seeger W, Grimminger F.
    Circulation; 2007 May 01; 115(17):2331-9. PubMed ID: 17438150
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Sildenafil in neonate pulmonary hypertension: the opinion of neonatology physician].
    Condò V, Colnaghi MR, Mosca E.
    Pediatr Med Chir; 2008 May 01; 30(3):156-8. PubMed ID: 19024860
    [No Abstract] [Full Text] [Related]

  • 20. [Pulmonary hypertension: the future has begun].
    Olschewski H.
    Med Klin (Munich); 2006 Apr 15; 101(4):328-33. PubMed ID: 16607490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.